Wellgistics Health, Inc. - 8-K Filing
Wellgistics Health, Inc. filed an 8-K to disclose a binding letter of intent for a $4 billion transaction involving intellectual property from EOS and SCLX, expanded licensing with Datavault AI, and acquisition of Tollo Health (Health Lives Here). The deal would issue preferred stock convertible into ~89.6% ownership to the involved parties. Additionally, it announced an amendment increasing a note payable by Robert Forster to $1.5 million after adding $200k in funding, appointed Gerald Commissiong as interim co-CEO, and approved a 1-for-50 reverse stock split effective May 26, 2025. (Items: 1.01 Entry into a Material Definitive Agreement, 2.03 Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant, 3.02 Unregistered Sales of Equity Securities, 3.03 Material Modification to Rights of Security Holders)
Tickers: $WGRX